The New Medical Genetics

The New Medical Genetics : Probing Social and Ethical Issues

Edited by  , Edited by  , Edited by 

List price: US$29.99

Currently unavailable

Add to wishlist

AbeBooks may have this title (opens in new window).

Try AbeBooks

Description

This book explores some of the conficts of interest between individual, familiar and societal needs that have arisen because of the rapid development of recombinant DNA technology in diagnostic testing. Some of the questions are purely scientific, while others are moral and ethical, involving conflicts between individuals, families and society. The book is arranged in four parts. Part one deals with presymptomatic diagnosis of a serious, untreatable disease (Huntington's Disease) and genetic, psychological and legal factors are discussed. Part two deals with prenatal diagnosis of variable conditions. Part three discusses the proper use of genetic informations and looks at ways to maximize the benefits of the new technology while minimizing its burden. Part four looks ahead to future studies that are needed to optimize the use of genetic information.show more

Product details

  • Hardback | 176 pages
  • 140 x 215mm
  • Oxford University Press Inc
  • New York, United States
  • English
  • 9 line drawings
  • 0195059034
  • 9780195059038

Table of contents

Part 1 The presymtomatic diagnosis of serious untreatable disease: genetic aspects, Huntington's disease, genetics and the G8 market, P.M.Conneally et al; psychological aspects, genetic choices, presymptomatic testing for Huntington's disease, N.S.Wexler; legal aspects, genetic discrimination, P.Reilly. Part 2 Prenatal diagnosis of conditions of variable manifestations: alphalantirypsin deficiency, ethical aspects of prenatal diagnosis, D.W.Cox; sickle cell anemia, a perspective on prenatal diagnosis, C.F.Whitten. Part 3 The proper use of genetic information: the problem of access to genetic data, P.Reilly; genetic screening and genetic information in the work place, B.Knoppers and H.Guay; the use of genetic information in evaluation insurability, L.D.Jones. Part 4 Pilot studies of new genetic services: predicting patient receptivity, a need for pilot programs and cost-benefit analysis, P.T.Rowley.show more